全文获取类型
收费全文 | 531173篇 |
免费 | 28403篇 |
国内免费 | 494篇 |
专业分类
耳鼻咽喉 | 6685篇 |
儿科学 | 16961篇 |
妇产科学 | 12552篇 |
基础医学 | 92862篇 |
口腔科学 | 12350篇 |
临床医学 | 48645篇 |
内科学 | 95894篇 |
皮肤病学 | 11908篇 |
神经病学 | 34245篇 |
特种医学 | 19797篇 |
外国民族医学 | 53篇 |
外科学 | 78432篇 |
综合类 | 7635篇 |
现状与发展 | 2篇 |
一般理论 | 107篇 |
预防医学 | 38683篇 |
眼科学 | 11936篇 |
药学 | 41486篇 |
1篇 | |
中国医学 | 1131篇 |
肿瘤学 | 28705篇 |
出版年
2019年 | 3921篇 |
2018年 | 5785篇 |
2017年 | 4155篇 |
2016年 | 4897篇 |
2015年 | 5400篇 |
2014年 | 7150篇 |
2013年 | 10561篇 |
2012年 | 15662篇 |
2011年 | 17479篇 |
2010年 | 10008篇 |
2009年 | 8884篇 |
2008年 | 15804篇 |
2007年 | 17536篇 |
2006年 | 17025篇 |
2005年 | 16361篇 |
2004年 | 15975篇 |
2003年 | 15333篇 |
2002年 | 14866篇 |
2001年 | 22512篇 |
2000年 | 23046篇 |
1999年 | 19004篇 |
1998年 | 5257篇 |
1997年 | 4388篇 |
1996年 | 4426篇 |
1995年 | 4150篇 |
1992年 | 14478篇 |
1991年 | 15868篇 |
1990年 | 16006篇 |
1989年 | 15674篇 |
1988年 | 14370篇 |
1987年 | 14262篇 |
1986年 | 13214篇 |
1985年 | 12734篇 |
1984年 | 9432篇 |
1983年 | 8022篇 |
1982年 | 4185篇 |
1979年 | 8958篇 |
1978年 | 6389篇 |
1977年 | 5162篇 |
1976年 | 5517篇 |
1975年 | 6623篇 |
1974年 | 7429篇 |
1973年 | 7170篇 |
1972年 | 6608篇 |
1971年 | 6315篇 |
1970年 | 5890篇 |
1969年 | 5469篇 |
1968年 | 5166篇 |
1967年 | 4628篇 |
1966年 | 3963篇 |
排序方式: 共有10000条查询结果,搜索用时 546 毫秒
51.
52.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
53.
54.
55.
56.
57.
Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient
下载免费PDF全文
![点击此处可从《Journal of clinical pharmacy and therapeutics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
58.
I. D. Petrova V. S. Petrov S. V. Seregin E. M. Malkova 《Molecular Genetics, Microbiology and Virology》2015,30(4):186-191
This paper presents an analysis of samples from 75 patients for the presence of rubella virus, viral RNA, and specific antibodies. For all samples, RNA detection was higher than virus isolation. It was found that it was not possible to isolate rubella virus in every sixth clinical sample containing the viral RNA. Primary structures of the site (from the 8072nd to 8291st nucleotide) of the rubella virus genome from 14 samples were determined. This paper shows that all the samples of rubella virus belong to the first genotype, subgroups 1h, and very likely to subgroups 1a and 1F. For the first time, the circulation of rubella virus of the genotype has been shown both prior to the start of mass vaccination in Western Siberia and after. 相似文献
59.
Nickel Allergy and Our Children's Health: A Review of Indexed Cases and a View of Future Prevention
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sharon E. Jacob M.D. Alina Goldenberg M.D. M.A.S. Janice L. Pelletier M.D. Luz S. Fonacier M.D. Richard Usatine M.D. Nanette Silverberg M.D. 《Pediatric dermatology》2015,32(6):779-785
Nickel is the leading cause of allergic contact dermatitis (ACD) from early childhood through adolescence. Studies have shown that skin piercings and other nickel‐laden exposures can trigger the onset of nickel ACD in those who are susceptible. Nickel ACD causes a vast amount of cutaneous disease in children. Cases of nickel ACD in children have been reported in peer‐reviewed literature from 28 states. Common items that contain inciting nickel include jewelry, coins, zippers, belts, tools, toys, chair studs, cases for cell phones and tablets, and dental appliances. The diagnosis of nickel ACD has been routinely confirmed by patch testing in children older than 6 months suspected of ACD from nickel. Unlike in Europe, there are no mandatory restrictions legislated for nickel exposure in the United States. Denmark has demonstrated that regulation of the nickel content in metals can lower the risk of ACD and the associated health care–related costs that arise from excess nickel exposure. To further awareness, this article reviews the prominent role of nickel in pediatric skin disease in the United States. It discusses the need for a campaign by caretakers to reduce nickel‐related morbidity. Lastly, it promotes the model of European legislation as a successful intervention in the prevention of nickel ACD. 相似文献